Showing results (261-270 of 279) with videos related to
Sort By:
Pageof 28
Bone Marrow Transplantation|August 10, 2004
High-dose chemotherapy with autologous stem cell transplantation in patients with oligometastatic breast cancerP Bojko, A Welt, R Schleucher, et al.Endocrine-Related Cancer|December 7, 2011
Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriersJonathan G Bijron, Petra van der Groep, Eleonora B van Dorst, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effectsM Stuschke, W Eberhardt, C Pöttgen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trialW Eberhardt, H Wilke, G Stamatis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumorsA Korfel, M E Scheulen, H J Schmoll, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 3, 2007
Breast cancer patients' expectations in respect of the physician-patient relationship and treatment management results of a survey of 617 patientsG Oskay-Ozcelik, W Lehmacher, D Könsgen, et al.Endocrine-Related Cancer|May 22, 2010
Methylation profiles of endometrioid and serous endometrial cancersLaura M S Seeber, Ronald P Zweemer, Luigi Marchionni, et al.Journal of Cancer Research and Clinical Oncology|September 2, 2008
Anthracyline-reduced sequential combination chemotherapy for younger patients with good-prognosis aggressive B-cell non-Hodgkin's lymphomaP Schütt, K Zimmermann, C Derks, et al.British Journal of Cancer|December 10, 1999
Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trialW Eberhardt, G Stamatis, M Stuschke, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.Pageof 28